Lacey McNally to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Lacey McNally has written about Xenograft Model Antitumor Assays.
Connection Strength
0.661
-
KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model. Clin Exp Metastasis. 2010 Dec; 27(8):591-600.
Score: 0.334
-
Targeted noninvasive imaging of EGFR-expressing orthotopic pancreatic cancer using multispectral optoacoustic tomography. Cancer Res. 2014 Nov 01; 74(21):6271-9.
Score: 0.110
-
Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation. Cancer Gene Ther. 2009 Mar; 16(3):246-55.
Score: 0.073
-
Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer. Cell Death Differ. 2019 10; 26(10):2100-2114.
Score: 0.037
-
Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide. Hum Gene Ther Clin Dev. 2014 Sep; 25(3):186-95.
Score: 0.027
-
Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model. Gynecol Oncol. 2011 Apr; 121(1):193-9.
Score: 0.021
-
Noninvasive monitoring of mRFP1- and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging. Mol Imaging. 2010 Apr; 9(2):59-75.
Score: 0.020
-
Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer. Clin Cancer Res. 2009 Jun 15; 15(12):4058-65.
Score: 0.019
-
Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging. Cancer Res. 2008 Oct 15; 68(20):8369-76.
Score: 0.018